We are live on ! Find out more
CCM

Chiron Capital Management Portfolio holdings

AUM $111M
This Fund
S&P 500
This Quarter Est. Return
+10.08%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$121M
AUM Growth
-$2.71M
Cap. Flow
-$12.4M
Cap. Flow %
-10.18%
Top 10 Hldgs %
66.14%
Holding
517
New
1
Increased
22
Reduced
44
Closed
435

Sector Composition

Rank Sector Weight
1 Healthcare 52.33%
2 Consumer Staples 6.59%
3 Energy 5.79%
4 Technology 5.35%
5 Financials 4.1%

Similar funds

Chiron Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Chiron Capital Management held 517 positions worth $121M, down 2.2% from $124M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Chiron Capital Management withdrew a net $12.4M in Q4 2020, closing 435 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $312K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 53% a quarter earlier, followed by Consumer Staples and Energy.

Against the trend, Chiron Capital Management opened a new position in Viatris worth $312K.

  • Chiron Capital Management's largest Q4 2020 buy was Viatris: 16,662 shares worth $312K.
  • Chiron Capital Management added most to Intel in Q4 2020, an estimated $2.5M increase.
  • Chiron Capital Management's biggest Q4 2020 reduction was Capital One, cutting an estimated $910K.
  • Chiron Capital Management fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $312K.
  • Chiron Capital Management's ten largest holdings make up 66% of its $121M portfolio in Q4 2020.
  • Chiron Capital Management opened 1 new position and closed 435 in Q4 2020.
  • Chiron Capital Management's portfolio value fell 2.2% quarter-over-quarter to $121M.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.